Exactech and Bodycad Sign Exclusive Distribution Agreement – To Offer Personalized Unicompartmental Knee Replacement

November 24, 2020

Exactech announced today the signing of an exclusive distribution agreement with orthopaedic manufacturer Bodycad for its Reflex Uni™ knee in the U.S.

This new product offering expands Exactech’s Truliant® primary and revision knee system to include a personalized unicompartmental implant that is designed to fit each patient’s unique anatomy. Truliant Reflex Uni is the latest addition to Exactech’s Active Intelligence® technology platform of personalized, data-driven solutions designed to improve patient outcomes.

Leveraging the latest in 3D printing technology, Truliant Reflex Uni was developed by Bodycad using a proprietary software algorithm and a fully integrated production system. Bodycad has developed an innovative 3D image rendering, digital planning, and production system to optimize personalized restoration of each patient’s anatomy. Bodycad’s proprietary software serves as the digital backbone to highly automate all processes.

The resulting patient-specific unicompartmental knee replacement requires no off-the-shelf implants and minimal instrumentation, making it ideally suited for an efficient hospital or ambulatory surgery center. In addition, Truliant Reflex Uni offers patients a better fit and potential for improved clinical results and satisfaction.

“Innovation in unicompartmental knee implants has been stagnant for years,” said John McDaniel, Exactech’s Senior Vice President, Large Joints. “We intentionally delayed offering a partial knee until we had something that could address the shortcomings of existing designs. With Truliant Reflex Uni, surgeons have the option to change implant design and placement to meet the needs of each patient. We’re excited about this personalized solution and its potential to maximize bone coverage, achieve proper alignment, and optimize joint function.”

“Bodycad’s indisputable expertise in the computer design of personalized unicompartmental prostheses united with the knowledgeable US sales force of Exactech is a union which will allow us to raise the success of a personalized joint restoration,” said CEO and Founder of Bodycad Jean Robichaud.

The Truliant Knee System is an award-winning platform of implants, instruments and technology that helps surgeons achieve reproducibility and efficiency in primary and revision knee arthroplasty. Exactech’s Active Intelligence portfolio connects surgeons and patients with smart decisions throughout the journey of care.

SourceExactech
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Led by researchers at NYU Grossman School of Medicine, the study results add to evidence that neighboring brain regions, the inferior frontal gyrus and the motor cortex, play an important role in such planning before words are said aloud. Both are part of the folded top layers of the brain, or cerebral cortex, which has long been known to control the muscle (motor) movements in the throat and mouth needed to produce speech. Less clear until now was how closely these regions determine the mix of sounds and words people want to say aloud, the authors report.
PolarisAR describes STELLAR Knee as a mixed-reality surgical navigation platform that guides TKA procedures by displaying measured and computed data overlaid directly in a 3D environment. The mixed-reality system acts as a spatial computer, creating continuous data exchange between the surgeon and the software to help enhance surgical decision-making while simplifying operating room workflow.
This February, the first enrolled patient underwent open surgical aortic arch reconstruction at the University of Pennsylvania, Presbyterian Medical Center, Philadelphia, PA.  During the surgery, the Duett Vascular Graft System was successfully deployed to connect the native left common carotid artery to the surgical graft.
"Our ultra low insertion loss Athermal AWG Multiplexers along with temperature-hardened low-drift AAWG specifically designed for the industrial temperature applications will be marketed aggressively through partnership companies in the East Asia and EU regions after its success in the North America," says Dr. Donald Yu, CMO of POINTek, who runs global marketing operations from Los Angeles, California.
AUX-001 is an innovative, once-daily, extended-release formulation of Nicorandil. For decades, immediate-release, twice daily Nicorandil has been a cornerstone treatment for chronic angina symptoms outside the US, distinguished by its dual mechanism of action that targets both the micro- and macrovascular coronary artery flow bed, and providing sustained angina symptom relief without the common issue of tachyphylaxis seen with other anti-anginal vasodilators like long-acting nitrates. AUX-001 offers efficacy comparable to conventional anti-anginal medications such as beta-blockers, calcium channel blockers, and long-acting nitrates while also potentially enhancing control of the underlying coronary disease and reducing angina related hospitalizations.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version